Show simple item record

dc.contributor.authorDennis, JM
dc.contributor.authorMcGovern, AP
dc.contributor.authorVollmer, SJ
dc.contributor.authorMateen, BA
dc.date.accessioned2020-12-17T09:34:49Z
dc.date.issued2020-10-26
dc.description.abstractOBJECTIVES: To measure temporal trends in survival over time in people with severe coronavirus disease 2019 requiring critical care (high dependency unit or ICU) management, and to assess whether temporal variation in mortality was explained by changes in patient demographics and comorbidity burden over time. DESIGN: Retrospective observational cohort; based on data reported to the COVID-19 Hospitalisation in England Surveillance System. The primary outcome was in-hospital 30-day all-cause mortality. Unadjusted survival was estimated by calendar week of admission, and Cox proportional hazards models were used to estimate adjusted survival, controlling for age, sex, ethnicity, major comorbidities, and geographical region. SETTING: One hundred eight English critical care units. PATIENTS: All adult (18 yr +) coronavirus disease 2019 specific critical care admissions between March 1, 2020, and June 27, 2020. INTERVENTIONS: Not applicable. MEASUREMENTS AND MAIN RESULTS: Twenty-one thousand eighty-two critical care patients (high dependency unit n = 15,367; ICU n = 5,715) were included. Unadjusted survival at 30 days was lowest for people admitted in late March in both high dependency unit (71.6% survival) and ICU (58.0% survival). By the end of June, survival had improved to 92.7% in high dependency unit and 80.4% in ICU. Improvements in survival remained after adjustment for patient characteristics (age, sex, ethnicity, and major comorbidities) and geographical region. CONCLUSIONS: There has been a substantial improvement in survival amongst people admitted to critical care with coronavirus disease 2019 in England, with markedly higher survival rates in people admitted in May and June compared with those admitted in March and April. Our analysis suggests this improvement is not due to temporal changes in the age, sex, ethnicity, or major comorbidity burden of admitted patients.en_GB
dc.description.sponsorshipDiabetes UK
dc.identifier.citationPublished online 26 October 2020en_GB
dc.identifier.doi10.1097/CCM.0000000000004747
dc.identifier.grantnumber20/0006220
dc.identifier.urihttp://hdl.handle.net/10871/124167
dc.language.isoenen_GB
dc.publisherLippincott, Williams & Wilkins / Society of Critical Care Medicineen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/33105150en_GB
dc.rights© 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en_GB
dc.subjectcoronavirus infectionen_GB
dc.subjectcritical careen_GB
dc.subjecthospital mortalityen_GB
dc.subjectpublic health surveillanceen_GB
dc.subjectquality of healthcareen_GB
dc.titleImproving Survival of Critical Care Patients With Coronavirus Disease 2019 in England: A National Cohort Study, March to June 2020en_GB
dc.typeArticleen_GB
dc.date.available2020-12-17T09:34:49Z
exeter.place-of-publicationUnited Statesen_GB
dc.descriptionThis is the final version. Available on open access from Lippincott, Williams & Wilkins via the DOI in this recorden_GB
dc.identifier.eissn1530-0293
dc.identifier.journalCritical Care Medicineen_GB
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
exeter.funder::Diabetes UKen_GB
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2020-10-26
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2020-12-17T09:32:43Z
refterms.versionFCDVoR
refterms.dateFOA2020-12-17T09:35:17Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2020 The Author(s).
Published by Wolters Kluwer Health,
Inc. on behalf of the Society of
Critical Care Medicine and Wolters
Kluwer Health, Inc. This is an open
access article distributed under
the Creative Commons Attribution
License 4.0 (CCBY), which permits
unrestricted use, distribution, and reproduction in any medium, provided
the original work is properly cited.
Except where otherwise noted, this item's licence is described as © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.